Angiogenesis Inhibition

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Liersch, Rüdiger (Επιμελητής έκδοσης), Berdel, Wolfgang E. (Επιμελητής έκδοσης), Kessler, Torsten (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2010.
Σειρά:Recent Results in Cancer Research, 180
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03290nam a22005055i 4500
001 978-3-540-78281-0
003 DE-He213
005 20151204181402.0
007 cr nn 008mamaa
008 100301s2010 gw | s |||| 0|eng d
020 |a 9783540782810  |9 978-3-540-78281-0 
024 7 |a 10.1007/978-3-540-78281-0  |2 doi 
040 |d GrThAP 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Angiogenesis Inhibition  |h [electronic resource] /  |c edited by Rüdiger Liersch, Wolfgang E. Berdel, Torsten Kessler. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2010. 
300 |a XIV, 231 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Recent Results in Cancer Research,  |x 0080-0015 ;  |v 180 
505 0 |a Angiopoietins -- HIF-1? and Cancer Therapy -- Chemokines -- Angiogenesis Inhibition in Cancer Therapy -- Vascular Integrins: Therapeutic and Imaging Targets of Tumor Angiogenesis -- PDGF and Vessel Maturation -- Lymphangiogenesis in Cancer: Current Perspectives -- Compounds in Clinical Phase III and Beyond -- Metronomic Chemotherapy: Principles and Lessons Learned from Applications in the Treatment of Metastatic Prostate Cancer -- Targeting Inflammatory Cells to Improve Anti-VEGF Therapies in Oncology -- Antibody-Based Vascular Tumor Targeting -- Caveolae and Cancer. 
520 |a Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials on therapeutic compounds are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in research and treatment in this exciting field. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Hematology. 
650 0 |a Oncology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Oncology. 
650 2 4 |a Hematology. 
650 2 4 |a Cancer Research. 
700 1 |a Liersch, Rüdiger.  |e editor. 
700 1 |a Berdel, Wolfgang E.  |e editor. 
700 1 |a Kessler, Torsten.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783540782803 
830 0 |a Recent Results in Cancer Research,  |x 0080-0015 ;  |v 180 
856 4 0 |u http://dx.doi.org/10.1007/978-3-540-78281-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)